Search Results for “artificial intelligence” – Page 4 – media

New AI system for lung cancer and heart disease

Artificial intelligence is gradually being adopted by health services to assist medics with the diagnosis of serious diseases. In one new development, scientists in Oxford, U.K. have launched an AI system for heart disease.
- Source: Digital Journal
- 961
- January 15, 2018
AI heart attacks lung cancer Researches
New AI technology significantly improves human kidney analysis

The ability to quantify the extent of kidney damage and predict the life remaining in the kidney, using an image obtained at the time when a patient visits the hospital for a kidney biopsy, now is possible using a computer model based on artificial intelligence (AI).
- Source: Medical Xpress
- 637
- January 12, 2018
AI kidney Researches
Microsoft and Adaptive Biotech to create universal blood test using AI

Microsoft has partnered with and invested in US-based Adaptive Biotechnologies to map the human immune system genetics using artificial intelligence (AI) for early detection and diagnosis of multiple diseases, including cancer.
- Source: Verdict Medical Devices
- 524
- January 8, 2018
AI Company Insight Microsoft
Picture of Health– Can AI Eye Scan Reveal What Ails You?

The light-sensitive layer found at the back of a person's eyes contains more than just cells that detect shadows and light — it also contains information about the health of a person's entire body. And now, artificial intelligence can glean this information from a single snapshot, new research suggests.
- Source: livescience
- 829
- December 13, 2017
Artificial Intelligence Optical coherence tomography Researches
For the First Time, a Robot Passed a Medical Licensing Exam

Experts generally agree that, before we might consider artificial intelligence (AI) to be truly intelligent —that is, on a level on par with human cognition— AI agents have to pass a number of tests. And while this is still a work in progress, AIs have been busy passing other kinds of tests.
- Source: futurism
- 494
- November 21, 2017
Artificial Intelligence
New Use of A.I. Accurately Detected Cancer 86 Percent of the Time

The quest to better detect cancer has made a potentially huge strides. A study out of Yokohama, Japan, has potentially harnessed artificial intelligence to help detect colorectal cancer even before benign tumors become malignant.
- Source: inverse
- 723
- November 1, 2017
Artificial Intelligence colorectal cancer Market Views
Is Jingtai Technology once again breaking through the “first AI pharmaceutical stock” halo and shedding?

Jingtai Technology, which has the halo of being the “first AI pharmaceutical stock” in China, has attracted considerable attention in the secondary market. In the past few months, it has always sparked discussions within the industry due to occasional breakthroughs. According to Wind, on November 19th, Jingtai Technology’s lowest intraday price was HKD 3.51 per share, hitting a new low since its listing. The closing price for the day was HKD 4.00 per share, a drop of 12.66%. Compared to its issue price of HKD 5.28 per share, it has dropped 24.24%. In fact, since September this year, the stock price of Jingtai Technology has shown an overall fluctuating downward trend. According to the official website of Jingtai Technology, it is an innovative research and development platform company driven by artificial intelligence (AI) and robots. Based on technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale ...
- Source: drugdu
- 35
- November 21, 2024
Yangqi Medical Chip completes tens of millions of yuan in Pre-A round financing

According to the Medicine Intelligence Data Investment Pattern Database, Yangqi Medical Chip, committed to becoming a pioneer in precision nuclear medicine, recently announced the completion of tens of millions of yuan in PreA round financing. This round of financing is led by Anfeng Venture Capital, and the raised funds will mainly be used for market promotion of approved products, approval of new product research and development, and expansion of the pet radiotherapy market. Yangqi Medical Core was established in 2021, and its core founding team is composed of clinical experts in nuclear medicine, nuclear physics and artificial intelligence, tumor radiotherapy, and radiation physics from Stanford, Alibaba, and other domestic and foreign institutions. The company is headquartered in Shenzhen and has research and development centers in Hangzhou and Shanghai. It is reported that Yangqi Medical Core is deeply involved in the fields of nuclear medicine and tumor radiation therapy. In response ...
- Source: drugdu
- 34
- November 21, 2024
374-year-old Chinese time-honored brand will change hands

On November 12, ST Jiuzhi issued a “Notice on the Transfer of Equity by the Controlling Shareholder and the Proposed Change of Control and Equity”. On November 10, Li Zhenguo, the controlling shareholder and actual controller of Jiuzhitang, signed the “Share Transfer Agreement on Jiuzhitang Co., Ltd.” with Heilongjiang Chenneng University of Technology Venture Capital, stipulating that Li Zhenguo will transfer his 6.25% stake in Jiuzhitang to Chenneng Venture Capital, and the total transfer amount of the target shares is about 385 million yuan. After the transfer is completed, Chenneng Venture Capital will become the controlling shareholder of ST Jiuzhi, with a controlling proportion of 24.04%, and the Heilongjiang Provincial State-owned Assets Supervision and Administration Commission will become the actual controller of ST Jiuzhi. Li Zhenguo holds 18.19% of ST Jiuzhi’s shares, making him the second largest shareholder. Specific changes in equity: It is worth mentioning that there were early ...
- Source: drugdu
- 49
- November 15, 2024
Wang Lei is discussing with lawyer

The first step in stock trading is to open a stock account On November 12th local time, Pascal Soriot, the global CEO of AstraZeneca, publicly responded for the first time to the detention of Wang Lei, the company’s China regional president. Suboko said, “Wang Lei is discussing with his lawyer, and the company does not have any new information about the case Suboko made the above response after the release of AstraZeneca’s third quarter financial report. He also said, “We attach great importance to the issues in the Chinese market and are taking measures to further strengthen compliance However, he denied that AstraZeneca headquarters lacked supervision over compliance. He said that the company has over 16000 employees in China, unfortunately some people may be tempted to maximize sales. He also stated that AstraZeneca has strengthened its compliance team of over 200 people in China and introduced resident compliance officers to ...
- Source: drugdu
- 51
- November 14, 2024

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.